Patent · US Active

Compositions and methods comprising antibodies that bind to covalent peptide conjugates

US12391770B2 · kind B2 · utility

0Cited by
4References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2024
Grant dateAug 19, 2025
Priority date
Expiry dateFeb 23, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/73
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are compositions and methods that include binding partners that bind with specificity to target sites on proteins or peptides that comprise a covalently attached molecule. The binding partners are provided as antibodies and antibody derivatives that specifically bind to proteins and peptides that have been covalently modified by attachment of a molecule, such as a drug. The binding partners can bind with specificity to covalently modified peptides when presented in the context of a major histocompatibility complex (MHC). Uses of the compositions and methods for prophylaxis or therapy of disorders are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.